Clinical Trial

Study Evaluating the Bioavailability of Miricorilant With Optional Food Effect Assessment in Healthy Adult Subjects

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This single-center, randomized, open-label study will assess the relative bioavailability of 2 miricorilant (CORT118335) tablet formulations.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-19.
Status change: Active, Not Recruiting → Completed 2026-04-07
Trial Details
NCT Number NCT07240116
Lead Sponsor Corcept Therapeutics
Conditions Healthy
Enrollment 18 participants
Start Date 2025-09-11
Primary Completion 2026-03-03 (estimated)
Study Completion 2026-03-03 (estimated)
Updated on ClinicalTrials.gov 2026-04-13